SGLT2 inhibitors and GLP1 agonists administered without metformin compared to other glucose‐lowering drugs in patients with type 2 diabetes mellitus to prevent cardiovascular events: A systematic review
Escobar C, Barrios V, Cosín J, et al
Diabet Med. 2021;38(3):e14502.
Leggi


